Althea Group Holdings Sells Pharmaceutical Segment, Withdraws Fiscal Year 2025 Guidance

MT Newswires Live

05/07

Althea Group Holdings (ASX:AGH) has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.

Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.

Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2533462266"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533462266\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533462266?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-07 11:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533462266","market":"hk","top_or_hot":-1,"title":"Althea Group Holdings Sells Pharmaceutical Segment, Withdraws Fiscal Year 2025 Guidance","media":"MT Newswires Live","content":"<html><body><p> Althea Group Holdings (ASX:AGH) has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.</p><p>Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.</p><p>Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Althea Group Holdings Sells Pharmaceutical Segment, Withdraws Fiscal Year 2025 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlthea Group Holdings Sells Pharmaceutical Segment, Withdraws Fiscal Year 2025 Guidance\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-05-07 11:36</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Althea Group Holdings (ASX:AGH) has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.</p><p>Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.</p><p>Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7096","symbol_name":"製藥","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2533462266","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533462266","pubTimestamp":1746589005,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Althea Group Holdings  has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7096":"制药","AGH.AU":"ALTHEA GROUP HOLDINGS LTD","BK7502":"大麻概念"},"translate_title":"Althea Group Holdings出售制药部门，撤回2025财年指引","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AGH.AU":0.9},"content_text":"Althea Group Holdings (ASX:AGH) has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}